.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 078230

« Back to Dashboard
NDA 078230 describes ROPINIROLE HYDROCHLORIDE, which is a drug marketed by Prinston Inc, Zydus Pharms Usa Inc, Alembic Ltd, Orchid Hlthcare, Corepharma, Watson Labs Inc, Glenmark Generics, Sandoz Inc, Wockhardt, Roxane, G And W Labs Inc, Mylan Pharms Inc, Apotex, Actavis Elizabeth, Dr Reddys Labs Ltd, Mylan, and Wockhardt Ltd, and is included in eighteen NDAs. It is available from thirty-three suppliers. Additional details are available on the ROPINIROLE HYDROCHLORIDE profile page.

The generic ingredient in ROPINIROLE HYDROCHLORIDE is ropinirole hydrochloride. There are fourteen drug master file entries for this compound. Thirty-five suppliers are listed for this compound. Additional details are available on the ropinirole hydrochloride profile page.

Summary for NDA: 078230

Tradename:
ROPINIROLE HYDROCHLORIDE
Applicant:
Corepharma
Ingredient:
ropinirole hydrochloride
Patents:0
Therapeutic Class:Antiparkinson Agents
Formulation / Manufacturing:see details

Pharmacology for NDA: 078230

Mechanism of ActionDopamine Agonists

Suppliers and Packaging for NDA: 078230

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ROPINIROLE HYDROCHLORIDE
ropinirole hydrochloride
TABLET;ORAL 078230 ANDA Rebel Distributors Corp 21695-792 21695-792-60 60 TABLET, COATED in 1 BOTTLE, PLASTIC (21695-792-60)
ROPINIROLE HYDROCHLORIDE
ropinirole hydrochloride
TABLET;ORAL 078230 ANDA Rebel Distributors Corp 21695-794 21695-794-60 60 TABLET, COATED in 1 BOTTLE, PLASTIC (21695-794-60)

Summary for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrengthEQ 0.25MG BASE
Approval Date:May 20, 2008TE:RLD:No

Summary for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrengthEQ 0.5MG BASE
Approval Date:May 20, 2008TE:RLD:No

Summary for product number 003

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrengthEQ 1MG BASE
Approval Date:May 20, 2008TE:RLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc